70934-705 NDC - BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE ()

Drug Information

Product NDC: 70934-705

Proprietary Name: bisoprolol fumarate and hydrochlorothiazide

Non Proprietary Name:

Active Ingredient(s):


Administration Route(s):

Dosage Form(s):

Labeler Information

Labeler Name: Denton Pharma, Inc. dba Northwind Pharmaceuticals
Product Type:
FDA Application Number:
Marketing Category:
Start Marketing Date:5/13/2020

Package Information

No. Package Code Package Description Billing Unit
170934-705-9090 TABLET in 1 BOTTLE, PLASTIC (70934-705-90)

NDC Record

Field Name Field Value Definition
PRODUCT NDC70934-705The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PROPRIETARY NAMEbisoprolol fumarate and hydrochlorothiazideThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
START MARKETING DATE5/13/2020This is the date that the labeler indicates was the start of its marketing of the drug product.
LABELER NAMEDenton Pharma, Inc. dba Northwind PharmaceuticalsName of Company corresponding to the labeler code segment of the Product NDC.

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 2/1/2023